ImmunoCellular Therapeutics Ltd (NYSE American:IMUC)

0.265
Delayed Data
As of 3:59pm ET
 0.00 / 0.00%
Today’s Change
0.17
Today|||52-Week Range
2.79
-16.14%
Year-to-Date
No recent news for ImmunoCellular Therapeutics Ltd.

Today’s Trading

Previous close0.27
Today’s open0.29
Day’s range0.27 - 0.29
Volume808,241
Average volume (3 months)2,264,723
Market cap$7.7M
Data as of 3:59pm ET, 04/24/2018

Growth & Valuation

Earnings growth (last year)-31.50%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book0.18

Competitors

 Today’s
change
Today’s
% change
SGLBSigma Labs Inc+0.02+1.56%
YTENYield10 Bioscience I...-0.03-1.57%
BASIBioanalytical System...-0.02-1.34%
OPGNOpGen Inc-0.15-7.32%
Data as of 4:00pm ET, 04/24/2018

Financials

Last reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$0.00
Annual profit (last year)-$22.1M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Secretary
Gary S. Titus
President, Chief Executive Officer &
Director
Anthony J. Gringeri
Corporate headquarters
Westlake Village, California

Forecasts